Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 26Terminated 13Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasm, Residual 1Leukemia, Hairy Cell 1Leukemia 1

Interventions

pembrolizumab 85Specimen Handling 78Carboplatin 73Magnetic Resonance Spectroscopy 70Biopsy 58Nivolumab 55Cisplatin 54Paclitaxel 46Cyclophosphamide 45durvalumab 37Radiotherapy 37Radiation 36olaparib 34Rituximab 34Etoposide 34Dexamethasone 33Ipilimumab 30Gemcitabine 30Doxorubicin 29Lenalidomide 28Taxes 27Docetaxel 27Pemetrexed 25Bevacizumab 24Prednisone 23Cytarabine 23X-Rays 22Vincristine 21Trastuzumab 21cabozantinib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Has results × Magnetic Resonance Imaging × Clear all
NCT00923013 2025-08-08

Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
175 enrolled 16 charts
Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡